From a clinical point of view, our data suggest that IL-7 (or inhibition GSK3 in macrophages) might be of value to prevent and treat infections in liver cirrhosis patients and thereby to prevent and ameliorate the development of ACLF and death. The gene discussed is IL7; the disease is cirrhosis of liver.